Corticosteroids and CABG in COPD Patients
Author Information
Author(s): Daniele Starobin, Mordechai R Kramer, Moshe Garty, David Shitrit
Primary Institution: Rabin Medical Center, Beilinson Campus, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Hypothesis
Does preoperative systemic corticosteroid administration reduce morbidity in COPD patients undergoing coronary artery bypass grafting?
Conclusion
Preoperative systemic corticosteroids may shorten ICU and hospital stays for COPD patients undergoing CABG.
Supporting Evidence
- The placebo group had more major nonpulmonary complications than the treatment group.
- The non-COPD control group had significantly fewer nonpulmonary complications than the COPD patients.
- Patients receiving steroids had a significantly shorter ICU stay than those receiving placebo.
Takeaway
Giving steroids before heart surgery can help patients with lung problems stay in the hospital for less time.
Methodology
A randomized trial with 90 patients, comparing corticosteroid treatment and placebo in COPD patients undergoing CABG.
Limitations
Small sample size and short follow-up period of 2 weeks.
Participant Demographics
60 patients with COPD and 30 controls, including both smokers and nonsmokers.
Statistical Information
P-Value
0.014
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website